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Independent predictors of CI-AKI using forward and backward stepwise logistic
regression analyses.
Cumulative Kaplan-Meier Estimates of the Rates of the Mortality During the
Follow-up Period
Independent predictors of mortality at follow up using stepwise PHH method.
Conclusion: Our study failed to show significant differences in AKI incidence between
patients with STEMI undergoing PPCI treated with different hydration strategies, in
particular bicarbonate didn’t result superior to saline infusion.
TCT-506
Invasive Treatment of Patients with Non-ST-Segment Elevation Myocardial
Infarction and Severe Renal Dysfunction - Early and 12-month Outcomes from
the PL-ACS Registry
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Background: The decision of invasive treatment of patients with non-ST-segment
elevation myocardial infarction (NSTEMI) and severe renal dysfunction (SRD) is
ambiguous. The aim of this analysis was to compare clinical presentation and 12-month
outcome of patients with NSTEMI and SRD treated invasively and non-invasively.
Methods: All patients with NSTEMI (N=10503) registered in Polish Registry of Acute
Coronary Syndromes (PL-ACS) from 7.2007 to 11.2009 were included. Glomerular
filtration rate (GFR) was estimated for each patient with the use of MDRD equation.
Follow-up mortality was obtained from the government database.
Results: Patients with severe renal dysfunction (GFR <= 30 mL/min/1.73m2) on
admission comprised only 5.5% of the analyzed population (N=575). Of them 38%
were treated invasively and they were of the lower risk profile. Patients treated
invasively were mostly revascularized by PCI, however 12% of them were referred to
bypass surgery. In-hospital as well as 12-month mortality was lower in patients treated
invasively. However, after multivariate adjustment invasive treatment of patients with
NSTEMI and SRD was no significantly associated with the lower 12-month mortality
(HR=0.84, 95%CI = 0.64-1.12, P=0.24).
Conclusion: Invasive treatment of selected patients with NSTEMI and severe renal
dysfunction seems to be safe and do not lead to higher mortality.
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Contrast Induced Nephropathy in Patients With Normal Renal Function
Undergoing Complex PCI with High Dose of Contrast Media : Predictive Value
of Cystatin C
Norbert Mayaud, Karl Isaaz, Christophe Mariat, Alexis Cerisier, Michel Lamaud,
Laure Richard, Antoine Da Costa
University Hospital, Saint Etienne, France
Background: Complex PCI of multiple vessel disease and chronic total occlusion may
require high dose of contrast media. The risk of contrast induced nephropathy (CIN)
in patients (pts) undergoing such interventions with baseline normal renal function is
unknown as well as the predictive value of Cystatin C (CyC), a marker of renal function
more sensitive than serum creatinine (SCr)
Methods: We evaluated 110 consecutive pts (90 males, age 60 ± 10 yrs) with MDRD
glomerular filtration rate (GFR) > 60 ml/min undergoing complex PCI with contrast
media volume > 400cc. SCr was measured at baseline, 24h, 48h, D6 and between 1
and 6 months after PCI. CyC was measured at baseline, 24h and 48 h post-PCI. Major
adverse events (MACE) including death of any cause, dialysis and TLR were assessed
at 6 months follow-up.
Results: Baseline Scr, MDRD GFR and CyC were 82 ± 14 μmol/l, 87 ± 19 ml/min
and 0.81 ± 0.19 mg/l, respectively. Contrast medium volume was 647±224 cc. CIN
defined as a +25% or +0.5mg/dl increase in Scr at 48h occurred in 11/111 pts (10%)
with persistent CIN at 30 days in only 4 pts (3.6%). No patient underwent dialysis.
MACE rates were similar in CIN and non-CIN pts (18% vs 6%, ns). CIN pts did not
differ from non-CIN pts regarding contrast medium dose, baseline SCr and MDRD
GFR. When compared with non-CIN pts, CIN pts had a greater baseline CyC (0.96±
0.25mg/l vs 0.80 ± 0.17mg/l, p=0.005), a lower weight (64 ±15 vs 78±14 kg, p=0.007),
a lower LVEF (47±19% vs 60±10‰, p=0.0006) and were more frequently smokers
(82% vs 41%, p=0.02). Multivariate analysis showed that baseline CyC ≥ 0.85mg/l
and LVEF ≤ 35% were the only independent predictive factors of CIN. None of the
pts with both baseline CyC < 0.85mg/l and EF > 35% (n=63) had a CIN despite very
high dose of contrast medium (mean 656cc, range 400-1150)
Conclusion: Our data suggest that very high volume of contrast medium can be safely
used if needed in PCI pts with normal baseline renal function providing Cystatin C is
below 0.85mg/l and left ventricular function is not severely depressed.
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The Dynamic Hemodialysis to Prevent Contrast-Induced Nephropathy in
Catheterization Laboratory
Osamu Matsuda, Tetsuo Matsubara, Akira Murata, Yoriyasu Suzuki, Suguru Murase,
Toshikazu Yamaguchi
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Background: In patients undergoing angiography, Contrast-Induced Nephropathy
(CIN) is a major controversial subject which accounts for significant morbidity and
mortality. Though several interventions have been used to prevent CIN, current
evidence does not support the use of prophylactic hemodialysis (HD) to prevent CIN.
Methods: We studied 103 patients with chronic renal impairment (mean serum
creatinine concentration 1.79±0.72 mg/dl), who underwent simultaneous HD during
both diagnostic and intervetional catheterization in catheterization laboratory. Serum
Creatinine (Scr) was measured to evaluate renal function. HD was started just before
administration of contrast media and continued 30min after procedure, and they were
monitored in catheter laboratory during procedure. Blood is driven through the
introducer placed in right atrium at a rate of 300ml/h, and dialysate flow was 500ml/h
without water removal. After extracorporeal circuit, blood was returned back to
saphenous vein. We monitored Scr before catheterization, 24 hours after the procedure
and at the selected time points between 3 to 10 days after the procedure. CIN defined
as an increase in the Scr of 0.5mg/dl or a 25% increase of the Scr at the following day.
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Results: There was 58% of CKD stage3 cases, and 42% of CKD stage 4 or 5. Emergent
catheterization was performed in 16% of cases, and cardiogenic shock with IABP was
5% of cases.All interventions were successfully performed, and no complication related
to HD was observed. Scr was measured 5.2±2.2 days after PCI. Of the 103 patients in
the study population, 6 (5.8 %) patients experienced CIN after PCI. Among CIN
patients, 5 patients were acute coronary syndrome (ACS) and 3 patients were shock
state and needed intra-aortic balloon pumping (IABP), 2 patients needed chronic HD
within a month and no patients died during hospital stay. There were 2 (2%) patients
who developed CIN among elective procedure.
Conclusion: In patients with reduced renal function, the strategy of performing
simultaneous HD during PCI appears to be effective in preventing the CIN.
TCT-509
High Concentration Sodium Bicarbonate for the Prevention Of Contrast-
induced Nephropathy
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Background: The appropriate dose of sodium bicarbonate to prevent contrast-induced
nephropathy (CIN) has not been established.
Methods: To determine the efficacy of high concentration sodium bicarbonate, sodium
bicarbonate was administrated at the rate of 3 ml/kg/h for 1 hour, followed by 1 ml/kg/h
for 7 hours, with/ without continuous hemodiafiltration (CHDF) to consecutive 181
patients with renal dysfunction (eGER of 60ml/min/1.73m2 or less) undergoing
coronary angiography with/without intervention according to the following 4 protocols:
for emergent patients, group E (n=23); 833 mEq/l solution starting as soon as possible
after admission, for elective patients, group H (n=87); 833 mEq/l starting 1 hour before
contrast exposure, Group L (n=36); 160 mEq/l starting 1hour before, Group M (n=35);
417 mEq/l starting 3 hours before. Protocol was determined depending on the study
period. Use of CHDF was at the discretion of operator in patients with severe renal
dysfunction and potential use of higher dose of contrast.
Results: Both incidence of CIN (1.5% vs 39.1%, p<0.001) and %change of creatinine
(1.1±19.7 vs 21.5±33.1, p<0.001) within 48 hours were lower in group H than in group
E. In the elective patients without CHDF, incidence of CIN was significantly lower in
group H (n=59) than group L (n=23) (0% vs 17.3%, p=0.005). Urine pH was increased
by dose and time dependent manner. In H, M, L groups, urine PH at 1 hour after
administration of sodium bicarbonates was higher than that of before administration
and higher at 3 hours after administration than those of 1 hour after and before
administration. In H, M,L groups, urine PH was 6.50±1.31, 6.46±1.29, 6.25±1.06 after
1 hour and 8.68±0.70, 7.33±1.40, 6.80±1.17 after 3 hours, respectively. The incidence
of CIN tended to be lower in patients with urine PH 6.5 than those with urine PH<6.5
(0% vs 13.0%, p=0.079) at the timing of contrast exposure. Side effects of sodium
bicarbonate were not observed.
Conclusion: Administration of higher dose of sodium bicarbonate was more effective
in terms of urine alkalization and prevention from CIN.
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Background: It’s not well known which Drug-Eluting Stents (DES) have better
outcome for dialysis patients.
Methods: We investigated 137 dialysis patients (225 lesions) treated with DES and
their prognosis. 57 lesions treated with Sirolimus-Eluting Stents (SES) from Sep. 2004
to May. 2009, 116 lesions treated with Paclitaxel-Eluting Stents (PES) from May. 2007
to Dec.2009, and 52 lesions treated with Everolimus-Eluting Stents (EES) from
Feb.2010 to Dec.2010 were enrolled in this study. We researched Target Lesion
Revascularization (TLR) after the procedure retrospectively.
Results: Mean follow-up duration was 1044, 590, and 268 days in each groups. The
difference of baseline characteristics were not significant except for osital lesion
(P=0.013), take-off lesion of LAD or LCx (P=0.006), and the existence of history of
heart failure (P=0.046) or multi vessel disease (P=0.007). PES group, compared with
SES and EES group, had less TLR (Log-rank test p=0.006). Multivariate Cox’s
proportional hazards analysis showed PES influence the reduction of TLR (HR 0.455,
0.241-0.859 [95%CI], p=0.015).
Conclusion: In mid-term follow-up, PES has a better clinical outcome for coronary
artery disease of dialysis patients compared with other DES.
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Tridimensional Rotational Angiography and Transplant Renal Artery Stenosis:
40 Cases Analysis
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Background: Transplant renal artery stenosis (TRAS) is the major vascular
complication associated with adverse events for patients with kidney allograft, whose
incidence varies from 1 to 23%. Angiography is the gold-standard method for
diagnostic and possible therapeutics, but due to the variable anatomy and the location
of the anastomosis, additional projections are often necessary, leading to an increased
contrast medium and radiation exposure. Therefore, 3D rotational angiography (3D-
RA) appears as an appealing tool for diagnosing TRAS and auxiliary in setting the
treatment strategy. The aim of this study was to evaluate measurements accuracy
between 3D-RA and conventional angiography.
Methods: From April, 2010 to May, 2011, 46 TRAS highly suspicious patients
underwent 3D-RA. Images analyses were performed by two independent observers
who executed measurements online for conventional angiography, while 3D-RA
measurements were carried out after images processing by Philips® Allure 3D-RA
software.
Results: 40 were used for comparison, 86.9% of those were enough for diagnosing
EART and 25% provided additional and relevant information for the therapeutic
strategy. There was no significant statistical difference between the measurements
obtained from both methods and also there was a strong correlation between them.
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